$EXFY Balance Sheet | Understand Stock

$EXFY

$2.44 -$0.07 (2.79%) Live

$EXFY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash and cash equivalents
Accounts receivable, net
Settlement assets, net
Prepaid expenses
Related party loan receivable
Other current assets
Total current assets
Capitalized software, net
Property and equipment, net
Lease right-of-use assets
Deferred tax assets, net
Other assets
Total assets

Liabilities and stockholders' equity
Accounts payable
Accrued expenses and other liabilities
Borrowings under line of credit
Current portion of long-term debt, net of original issue discount and debt issuance costs
Lease liabilities, current
Settlement liabilities
Total current liabilities
Lease liabilities, non-current
Deferred tax liabilities, net
Other liabilities
Long-term debt, net of original issue discount and debt issuance costs
Total liabilities
Convertible preferred stock, par value $0.0001; 0 and 4,203,139 shares authorized, issued and outstanding as of December 31, 2021 and 2020, respectively; (aggregate liquidation preference of $0 and $24,929,457 as of December 31, 2021 and 2020, respectively)
Stockholders' equity:
Preferred Stock, Value, Issued
Common stock, shares authorized (in shares)
Common stock, shares issued (in shares)
Common stock, shares outstanding (in shares)
Common stock, par value (in dollars per share)
Common stock issued, value
Additional paid-in capital
Subscriptions receivable (including accrued interest of $0)
Accumulated deficit
Total stockholders' equity

Total liabilities and stockholders' equity

Comments